Year |
Citation |
Score |
2009 |
Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, Kirken RA. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. Molecular Cancer. 8: 67. PMID 19709433 DOI: 10.1186/1476-4598-8-67 |
0.549 |
|
2009 |
Utama FE, Tran TH, Ryder A, LeBaron MJ, Parlow AF, Rui H. Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells. Endocrinology. 150: 1782-90. PMID 19022890 DOI: 10.1210/En.2008-1057 |
0.573 |
|
2008 |
Nagy ZS, LeBaron MJ, Rui H, Kirken RA. 184 The NFκB regulator Bcl10 is a novel Stat5 target gene Cytokine. 43: 283. DOI: 10.1016/J.Cyto.2008.07.246 |
0.506 |
|
2007 |
LeBaron MJ, Ahonen TJ, Nevalainen MT, Rui H. In vivo response-based identification of direct hormone target cell populations using high-density tissue arrays. Endocrinology. 148: 989-1008. PMID 17138649 DOI: 10.1210/En.2006-1219 |
0.566 |
|
2006 |
Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, Rui H. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. The Journal of Endocrinology. 188: 589-601. PMID 16522738 DOI: 10.1677/joe.1.06560 |
0.541 |
|
2005 |
Rui H, LeBaron MJ. Creating tissue microarrays by cutting-edge matrix assembly. Expert Review of Medical Devices. 2: 673-80. PMID 16293094 DOI: 10.1586/17434440.2.6.673 |
0.477 |
|
2005 |
LeBaron MJ, Crismon HR, Utama FE, Neilson LM, Sultan AS, Johnson KJ, Andersson EC, Rui H. Ultrahigh density microarrays of solid samples. Nature Methods. 2: 511-3. PMID 15973421 DOI: 10.1038/Nmeth772 |
0.464 |
|
2005 |
LeBaron MJ, Xie J, Rui H. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Molecular Cancer. 4: 6. PMID 15686596 DOI: 10.1186/1476-4598-4-6 |
0.579 |
|
2005 |
Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene. 24: 746-60. PMID 15592524 DOI: 10.1038/Sj.Onc.1208203 |
0.58 |
|
2004 |
Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ, Pretlow TG, Ealley EL, Zhang Y, Nurmi M, Singh B, Martikainen PM, Nevalainen MT. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Research. 64: 4774-82. PMID 15256446 DOI: 10.1158/0008-5472.Can-03-3499 |
0.418 |
|
2003 |
Ahonen TJ, Xie J, LeBaron MJ, Zhu J, Nurmi M, Alanen K, Rui H, Nevalainen MT. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. The Journal of Biological Chemistry. 278: 27287-92. PMID 12719422 DOI: 10.1074/Jbc.M304307200 |
0.566 |
|
2002 |
Xie J, LeBaron MJ, Nevalainen MT, Rui H. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. The Journal of Biological Chemistry. 277: 14020-30. PMID 11821424 DOI: 10.1074/Jbc.M112399200 |
0.598 |
|
2001 |
Yamashita H, Nevalainen MT, Xu J, LeBaron MJ, Wagner KU, Erwin RA, Harmon JM, Hennighausen L, Kirken RA, Rui H. Role of serine phosphorylation of Stat5a in prolactin-stimulated β-casein gene expression Molecular and Cellular Endocrinology. 183: 151-163. PMID 11604235 DOI: 10.1016/S0303-7207(01)00546-9 |
0.54 |
|
Show low-probability matches. |